News
GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...
QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services ...
Over the last decade there has been a move to reduce the amount of preclinical work requiring the use of sentient animals.
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
CorWave, a medical device company dedicated to the fight against heart failure, announces new preclinical results of its implantable heart pump.
Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is ...
A common gastrointestinal cancer drug that crosses the blood-brain barrier showed promise in patients with aggressive ...
13d
Medical Device Network on MSNSource BioScience enhances clinical diagnostics portfolio with CCL acquisitionAccording to Source BioScience, the acquisition is set to “complement” its genomics and multiomics capabilities, broadening ...
Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual meeting: Berlin, Germany Wednesday, April 23, 2025, 10:00 Hrs ...
A rice-sized microrobot offers precision in brain surgery, starting with tumor biopsies in a first clinical trial set for ...
Highlights of BioNTech's oncology programs to be presented at AACR 2025: ...
NurExone's ExoTherapy platform enables precise, minimally-invasive delivery of therapies to injured tissues using exosomes as an advanced delivery system. With a growing body of preclinical data and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results